ONLINE
ORDER


| List of Tetramer | ||||
| Allele: | Peptide: | Antigen: | Category: | Cat. No.: |
| HLA-B*40:01 | Empty | None | HB40-001 | |
| HLA-B*27:05 | Empty | None | HB27-001 | |
| HLA-B*15:02 | Empty | None | HB1502-001 | |
| HLA-B*15:01 | Empty | None | HB1501-001 | |
| H-2Db | KAVYNFATM | LCMV GP1 33-41 (C9M) | Influenza | MDb-017 |
| HLA-A*02:01 | RLYNGLKFI | Tetanus toxin | Bacteria | HA02-206 |
| HLA-A*03:01 | TTAPSLSGK | β-catenin 20-49 | Cancer | HA03-022 |
| HLA-A*03:01 | TTAPPLSGK | β-catenin 20-49 (S24P) | Cancer | HA03-021 |
| HLA-A*03:01 | TTAPFLSGK | β-catenin 20-49 (S24F) | Cancer | HA03-020 |
| HLA-A*11:01 | TTAPSLSGK | β-catenin 20-49 | Cancer | HA11-033 |
| HLA-A*11:01 | TTAPPLSGK | β-catenin 20-49 (S24P) | Cancer | HA11-032 |
| HLA-A*11:01 | TTAPFLSGK | β-catenin 20-49 (S24F) | Cancer | HA11-031 |
| H-2Db | WMHHNMDLI | miHAg UTY 246-254 | Graft vs Host | MDb-015 |
| H-2Db | SSLENFRAYV | Influenza A (PR8) Polymerase PA 224-233 | Influenza | MDb-014 |
| H-2Db | SCLENFRAYV | Influenza A polymerase PA 224-233 | Influenza | MDb-012 |
| H-2Db | RMFPNAPYL | WT-1 126-134 (Wilms tumor) | Cancer | MDb-011 |
| H-2Db | RAHYNIVTF | HPV 16 E7 49-57 | HPV | MDb-010 |
| H-2Db | KVPRNQDWL | gp100 (pmel17) 25-33 | Cancer | MDb-009 |
| H-2Db | HGIRNASFI | MCMV m45 985-993 | CMV | MDb-007 |
| H-2Db | SGVENPGGYCL | LCMV GP 276-286 | LCMV | MDb-013 |
| H-2Db | KAVYNFATC | LCMV GP1 33-41 | LCMV | MDb-008 |
| H-2Db | FQPQNGQFI | LCMV NP 396-404 | LCMV | MDb-006 |
| H-2Db | CMTWNQMNL | WT1 235-243 | Cancer | MDb-005 |
| H-2Db | ASNENMETM | Influenza A (PR8) NP 366-374 | Influenza | MDb-004 |
| H-2Db | ASNENMDAM | Influenza A (NT60) NP 366-374 | Influenza | MDb-003 |
| H-2Db | Empty | None | Empty | MDb-016 |
| H-2Db | ASFRNLTHL | TPBG 258-266 | Cancer | MDb-002 |
| H-2Db | AGPHNDMEI | HSV p56 487-495 | HSV | MDb-001 |
| HLA-A*01:01 | TLDTLTAFY | Mesothelin 429-437 | HA01-008 | |
| HLA-A*01:01 | SADNNNSEY | AAV VP1 492-500 | HA01-007 | |
| HLA-A*01:01 | KSDICTDEY | Tyr 243-251 (244S) | HA01-006 | |
| HLA-A*01:01 | IVDCLTEMY | A1-HY DRRFY (1521-1529) | HA01-005 | |
| HLA-A*01:01 | EVDPIGHLY | MAGE-A3 168-176 | HA01-004 | |
| HLA-A*01:01 | DSDPDSFQDY | Tyr A1a 454-463 | HA01-003 | |
| HLA-A*01:01 | ATDALMTGF | Influenza A (PR8) NP 44-52 | HA01-002 | |
| HLA-B*08:01 | Empty | None | HB08-011 | |
| HLA-B*08:01 | ELRSRYWAI | NP 380-388 | HB08-010 | |
| HLA-B*08:01 | QAKWRLQTL | EBNA3A 158-166 | HB08-009 | |
| HLA-B*08:01 | AAKGRGAAL | Negative control | HB08-008 | |
| HLA-B*08:01 | YLKDQQLL | HIV Env 586-593 | HB08-007 | |
| HLA-B*08:01 | RAKFKQLL | EBV BZLF-1 190-197 | HB08-006 | |
| HLA-B*08:01 | FLKEKGGL | HIV-1 nef 90-97 | HB08-003 | |
| HLA-B*08:01 | HSKKKCDEL | HCV NS3 1395-1403 | HB08-005 | |
| HLA-B*08:01 | FLRGRAYGL | EBV EBNA-3A 193-201 | HB08-004 | |
| HLA-B*08:01 | ELKRKMIYM | IE-1 199-207 | HB08-001 | |
| HLA-B*08:01 | ELRRKMMYM | IE-1 199-207 | HB08-002 | |
| HLA-A*01:01 | ATDALMTGF | HCV NS3 1436-1444 | HA01-010 | |
| HLA-A*01:01 | VTEHDTLLY | HCMV pp50 245-253 | HA01-009 | |
| HLA-A*11:01 | STRDPLSEITK | PIK3CA E545K | Cancer | HA11-030 |
| HLA-A*11:01 | VVVGARGVGK | KRAS | Cancer | HA11-029 |
| HLA-A*11:01 | VVVGAGDVGK | KRAS | Cancer | HA11-028 |
| Custom Antigen | Custom Antigen | Custom Antigen | B cell detection | CAg-001 |
| H-2Kb | KSPWFTTL | MuLV p15E | Cancer | MKb-032 |
| H-2Kb | ISGQHLVAV | Nucleophosmin | Cancer | MKb-029 |
| H-2Kb | ITPPVVLRL | Nucleophosmin | Cancer | MKb-028 |
| H-2Kb | QNYLFGCEL | Nucleophosmin | Cancer | MKb-027 |
| H-2Kb | EIINFEKL | Ovalbumin 257-264 variant | Model | MKb-031 |
| H-2Kb | SIIQFEHL | Ovalbumin 257-264 variant | Model | MKb-030 |
| H-2Kb | VNFNFNGL | SARS-CoV-2 (S) | MKb-023 | |
| HLA-A*02:01 | YAMSNLFSI | HERV-K | HERV | HA02-205 |
| H-2Kb | DTLVNRIEL | eGFP 118–126 | MKb-026 | |
| H-2Kb | LMYRFEEEL | Luciferace 264-272 | MKb-025 | |
| HLA-A*02:01 | KLIDCYTFL | HERV-K | HERV | HA02-204 |
| HLA-A*02:01 | AMIPKDWPL | HERV-K | HERV | HA02-203 |
| HLA-A*02:01 | RLIPYDWEI | HERV-K | HERV | HA02-202 |
| HLA-A*02:01 | FLQFKTWWI | HERV-K | HERV | HA02-201 |
| HLA-A*01:01 | Empty | None | HA01-001 | |
| HLA-E*01:03 | Empty | None | HE01-001 | |
| HLA-A*24:02 | RYSIFFDY | EBNA3A 246-253 | EBV | HA24-036 |
| HLA-A*24:02 | DYCNVLNKEF | BRLF1 28-37 | EBV | HA24-035 |
| HLA-A*24:02 | YLAMPFATPME | NY-ESO-1 91-101 | Cancer | HA24-034 |
| HLA-A*11:01 | KITDFGLAK | EGFR | Cancer | HA11-027 |
| HLA-A*11:01 | KITDFGRAK | EGFR L858R | Cancer | HA11-026 |
| HLA-A*11:01 | VVVGACGVGK | KRAS G12C | Cancer | HA11-025 |
| HLA-A*11:01 | VVVGAGGVGK | KRAS | Cancer | HA11-024 |
| HLA-A*11:01 | VVGAVGVGK | KRAS G12V 8-16 | Cancer | HA11-020 |
| HLA-A*11:01 | ATIGTAMYK | BRLF1 134-142 | EBV | HA11-019 |
| HLA-A*11:01 | GPISGHVLK | pp65 16-14 | CMV | HA11-018 |
| HLA-A*11:01 | GPISGHVLK | pp65 16-14 | CMV | HA11-017 |
| HLA-A*11:01 | AVFDRKSDAK | EBNA3B 399-408 | EBV | HA11-016 |
| HLA-A*11:01 | VVVGAVGVGK | KRAS G12V 7-16 | Cancer | HA11-022 |
| HLA-A*11:01 | IVCPICSQK | HPV16 E7 | HPV16 | HA11-014 |
| HLA-A*11:01 | TTLEQQYNK | HPV16 E6 93-101 | HPV16 | HA11-013 |
| HLA-A*03:01 | VVVGAVGVGK | KRAS G12V 7-16 | Cancer | HA03-019 |
| HLA-A*03:01 | VVGAVGVGK | KRAS G12V 8-16 | Cancer | HA03-018 |
| HLA-A*03:01 | VVVGAGGVGK | KRAS | Cancer | HA03-017 |
| HLA-A*03:01 | VVVGACGVGK | KRAS G12C | Cancer | HA03-016 |
| HLA-A*03:01 | VVVGADGVGK | KRAS G12D | Cancer | HA03-015 |
| HLA-A*03:01 | KITDFGLAK | EGFR | Cancer | HA03-014 |
| HLA-A*03:01 | KITDFGRAK | EGFR L858R | Cancer | HA03-013 |
| HLA-A*03:01 | RVLSFIKGTK | NP 342–351 | CEF | HA03-012 |
| HLA-A*03:01 | RVRAYTYSK | BRLF1 148-156 | EBV | HA03-011 |
| HLA-A*03:01 | TVYPPSSTAK | pp150 946-955 | CMV | HA03-010 |
| HLA-A*03:01 | RLRAEAQVK | EBNA3A 603-611 | EBV | HA03-009 |
| HLA-A*03:01 | ILRGSVAHK | NP 265-274 | Influenza | HA03-008 |
| HLA-A*03:01 | TTVYPPSSTAK | pp150 945-955 | CMV | HA03-007 |
| HLA-A*02:01 | SLYSYFQKV | SLC45A2 | Cancer | HA02-199 |
| HLA-A*02:01 | CLAVEEVSL | NPM1 | AML | HA02-198 |
| HLA-A*02:01 | AIQDLCLAV | NPM1 | AML | HA02-197 |
| HLA-A*02:01 | MLNIPSINV | pp65 120-129 | CMV | HA02-196 |
| HLA-A*02:01 | KLVVVGAGGV | KRAS | Cancer | HA02-195 |
